State Street SPDR S&P Biotech ETF

State Street SPDR S&P Biotech ETF is an ETF issued by State Street Corp. on Jan 31 2006. The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care". As of today, the price of XBI ETF according to its net asset value is discounted at -0.01%. While the total value of the fund shows $-1,562,512,833 decrease compared to the previous month, its price is traded daily at a decrease of -0.84%. The annual dividend yield of XBI ETF is 0.33%, whereas its main asset area is North America. XBI ETF, whose 24-hour total volume is $6.22M, has experienced a $-634,639,164 cash outflow in the last month. In addition, State Street SPDR S&P Biotech ETF's one-year net asset value total return is 67.90%.